AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2016
Nov 10, 2016
34931_dirs_2016-11-10_0f839d4b-1550-47dc-a836-5e1226aeaee9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Caladrius Biosciences, Inc. (CLBS)
CIK: 0000320017
Period of Report: 2016-10-25
Reporting Person: Preti Robert A (Director, See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-10-25 | Common Stock | F | 164 | $4.12 | Disposed | 26331 | Direct |
Footnotes
F1: Includes 4,268 shares of unvested restricted stock.